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Microvesicles (MVs) serve as vectors of nucleic-acid dissemination and are important 
mediators of intercellular communication. However, the functionality of packaged nucleic 
acids on recipient cells following transfer of MV-cargo has not been clearly elucidated. This 
limitation is attributed to a lack of methodology available in assessing protein translation 
following homotypic intercellular transfer of nucleic-acids. Using surface peptide shaving we 
have demonstrated that MVs derived from human leukaemic cells transfer functional P-
glycoprotein transcripts, conferring drug-efflux capacity to recipient cells. We demonstrate 
expression of newly synthesized protein using Western blot. Furthermore, we show 
functionality of translated P-gp protein in recipient cells using Calcein-AM dye exclusion 
assays on flow cytometry. Newly synthesized 170 kDa P-gp was detected in recipient cells 
after co-culture with shaven MVs and these proteins were functional, conferring drug-efflux. 
This is the first demonstration of functionality of transferred nucleic-acids between human 
homotypic cells as well as the translation of the cancer multidrug-resistance protein in 
recipient cells following intercellular transfer of its transcript. This study supports the 
significant role of MV’s in the transfer of deleterious traits in cancer populations and 
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MVs (Microvesicles) are shed from a diverse range of eukaryotic and prokaryotic 
cells either spontaneously or following cellular activation or stress (1) . They selectively 
transfer the phenotypic and genotypic characteristics of their parental cell by packaging 
proteins and nucleic acids upon vesiculation (1-4). MV’s have been shown to participate in a 
variety of processes involving the development of immune tolerance, immune activation, 
phenotype modification, cell-cell signalling, drug-sequestration and reprogramming of cell 
function (1, 3-6). Numerous studies have demonstrated the presence of RNA, mRNA and 
miRNA in MVs (1, 4, 6-8), with some nucleic acid species being either selectively packaged or 
completely absent during the MV vesiculation and transfer processes (1, 6). Consequently, 
MVs have emerged as important vehicles for nucleic acid based communication between 
cells.   
  In assessing functionality of the transferred nucleic acid cargo, previous studies 
have used interspecies methodologies to establish nucleic acid functionality following 
intercellular transfer by MV’s (8). However, this approach is not physiologically relevant due 
to interspecies differences, which may impact on protein translation of the foreign 
transcript in recipient cells. Furthermore, there have been no technical means to distinguish 
between the translation of conferred transcript and the transfer of endogenous protein 
contained within the MV cargo, hence confounding results. Other attempts to detect 
protein translation from MV-RNA have utilised labelled probes such as luciferase reporter 
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genes (7). Once again this does not reflect the native nucleic acid cargo of MV’s. 
Consequently, the functionality of transferred native MV-RNA between homotypic cells has 
remained unestablished.  
Herein, we demonstrate for the first time, the translation of native human MV-RNA 
in recipient human cells following intercellular transfer by MV’s. This study establishes the 
functionality of human MV-nucleic acids encoding transmembrane proteins by employing 
MV surface peptide shaving.  We anticipate this methodology will be used to assess the 
expression of membrane bound proteins in the context of MV-transfer. This study 
demonstrates for the first time that MV’s confer phenotypic changes in recipient cells 
following the transfer of functional nucleic acids in addition to the transfer of functional 
proteins and reinforces the significance of MV’s in the acquisition cellular traits.  
MATERIALS AND METHODS 
Cell Lines 
The drug sensitive human acute lymphoblastic leukaemia cell line CCRF-CEM 
(designated CEM for simplicity) and its MDR derivative, VLB100 was used in this study. VLB100 
cells hyper-express functional cell surface P-gp relative to the parental drug sensitive CCRF-
CEM cells. The CEM and VLB100 cell lines have been validated earlier by us as an appropriate 
model for study of P-gp mediated MDR in vitro (3, 9, 10). All cell lines were cultured in RPMI-
1640 media (Sigma-Aldrich, NSW, Australia), supplemented with 10% heat-inactivated foetal 
bovine serum (Invitrogen, Life Technologies, Victoria, Australia) and maintained at 37
0
C and 
5% CO2. All cells lines were tested for mycoplasma contamination routinely. 
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MV isolation  
MVs were isolated from 5 x 10
9
 – 7 x 10
9
 cells by differential centrifugation, as 
described previously (3, 4, 11). The integrity and purity of the isolated MV fraction have 
been previously extensively validated by us (3, 4). This amount yields approximately 2 mg of 
total MV protein in 100 µL final volume.  Briefly, cell supernatant was collected and 
centrifuged at 500 × g for 5 min to pellet the cell population or debris. The supernatant was 
further centrifuged at 15,000 × g for 1 h at 15
0
C and the pellet was resuspended in serum 
free RPMI-1640. The MV fraction was further centrifuged at 2000 × g for 1 min to remove 
remaining debris. To concentrate the MV fraction, the supernatant was further centrifuged 
at 18,000 × g for 30 min and resuspended in serum free RPMI-1640. MV total protein 
content was quantified using Qubit®2.0 Fluorometer protein assay (Invitrogen, Life 
Technologies) as per the manufacturer’s instructions. 
Flow Cytometric analysis 
 To confirm the presence of nucleic acids in MVs, flow cytometric analysis (LSRII, BD 
Biosciences, CA, USA) was used following acridine orange (AO) (Sigma-aldrich) staining. 
Cytograms were acquired using BD FACSDiva software (BD Biosciences) and analyzed using 
BD Cell-Quest Pro (BDBiosciences). Approximately 50 µg of MVs were treated with RNAse A 
(Invitrogen, Life technologies) and resuspended in 200 µL of RPMI
-
 and incubated with AO to 
a final concentration of 20 µmol/L. Unstained MVs were used as the control.  
MV integrity was assessed using the calcein-AM (Invitrogen, Life technologies drug 
exclusion assay. Calcein-AM is a non-fluorescent membrane permeable drug. Upon entering 
MVs, calcein-AM is cleaved by endogenous esterases to its fluorescent non-membrane 
permeable form, calcein (4). Approximately 50 µg of MVs were stained with 0.1 µM calcein-
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AM for 1 h at 37
o
C and 5% CO2. MVs were washed twice with PBS to remove unincorporated 
calcein-AM and resuspended in 200 µL of PBS for flow cytometric analysis.  
For cell-MV binding studies, MVs are stained with the cell membrane dye PKH26 
(sigma-aldrich) for 1 minute according to the manufacturer’s instructions, immediately 
followed by two washes with PBS at 18,000 x g. MVs are then immediately analysed on the 
flow cytometer or used in co-culture experiments with recipient CEM cells.  
In assessing cell binding of MV’s to recipient cells, 1 x 10
5
 CEM cells were co-cultured 
in a 96 well plate at 37
o
C, 5% CO2 for 4 h with 180 µg of MVs preloaded and labelled with 
calcein-AM, AO and PKH26 MVs respectively. The 4h time point has been previously 
validated by us to be sufficient time for the transfer of functional protein and nucleic 
material from MV’s to recipient cells (3, 4, 6, 12). Cells are subsequently washed thrice with 
PBS at 500 x g for 5 min at room temperature to remove unbound MVs. Cells were 
resuspended in 200 µL of PBS before analysis on the flow cytometer. 
In vitro rabbit reticulocyte translation  
The in vitro rabbit reticulocyte translation kit (Promega, NSW, Australia) was used 
according to the manufacturers instruction with the exception that a total of 400 µg/mL 
final concentration of total MV RNA was used to obtain efficient translation of P-gp/ABCB1 
from MV’s. A rabbit reticulocyte lysate sample without RNA was used as the control.  
Samples were immediately stored at -20
o
C until required.  
Total RNA was isolated from MVs and cells using the RNeasy mini kit with genomic 
DNA eliminator (Qiagen, NSW, Australia). 300 µg – 1 mg MVs were pelleted at 18,000 x g 
and disrupted and homogenized using 350-600 μL of buffer RLT plus (Qiagen, NSW, 
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Australia). Purified total RNA was isolated from the homogenate according to the 
manufacturer’s protocol. The RNA isolate was resuspended in 30 μL of RNAse free H2O and 
quantified using the Nanodrop 1000 spectrophotometer (Nanodrop technologies, DE, USA). 
Purified total RNA was stored at -80
o
C until required.     
 
SDS-PAGE and Trypsin in-gel digestion 
4 µL of rabbit lysate, as prepared above, was mixed with 2x SDS sample buffer 
containing Tris-HCl, glycerol, SDS, bromophenol blue and water (pH 8.8) at a ratio of 2:1 
(protein : SDS buffer). The sample was sonicated in a waterbath for 5 min followed by 
centrifugation for 5 min at 16,500 x g at ambient temperature. Proteins were separated 
using 4-10% SDS-PAGE at a voltage of 150 V in MES SDS running buffer (Invitrogen, Life 
Technologies). The gel was fixed with 40% Methanol / 10% Acetic acid for 30 min with 
gentle shaking before staining with Coomassie blue overnight. In-gel trypsin digestion was 
performed as previously described by us (2). Briefly, the gel was sectioned into 12 pieces, 
according to the MW markers and the sections diced into 1 x 1 mm pieces which were de-
stained by adding 50% acetonitrile (ACN)/50 mM NH4HCO3 and incubated for 10 min at 
ambient temperature. The process was repeated until the Coomassie stain disappeared. 
100% ACN was added to dehydrate the gel pieces before rehydration with 12.5 ng/µL of 
trypsin solution (Trypsin Gold-MS grade, Promega) and overnight incubation at 37°C. After 
incubation, the supernatant was collected after sonication in a water-bath for 10 min, 
followed by another sonication following the addition of 30 µl of 50% ACN/2% formic acid. 
The solution was added to the previously collected peptides and the volume reduced to 15 
µL by rotary evaporation. The peptide solution was centrifuged at 14,000 x g for 10 min to 
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remove any insoluble material prior to LC/MS/MS analysis. LC/MS/MS experiments and 
analysis was performed as described previously (2).  
MV surface shaving 
To determine whether ABCB1 transcript packaged in MVs could be transferred and 
translated in human recipient cells, we used surface shaving methodology to eliminate 
endogenously packaged transmembrane proteins on the MV membrane using proteinase K 
digestion prior to co-culture with recipient cells. Our approach allows for the detection of 
newly synthesized transmembrane protein in recipient cells and eliminates endogenous 
protein present in MV’s, which would confound the results. Briefly, the MV pellet was 
resuspended in PBS, pH 7.8 at room temperature. Samples, including proteinase K were pre-
warmed for 15 min in 37
o
C. 20-200 ng/mL of proteinase K was added to the MV sample and 
incubated for 5 min at 37
o
C. To stop the reaction, protease cocktail (1%) (Sigma-Aldrich) was 
immediately added to the sample. MVs were washed twice with ice cold PBS for 18, 000 x g 
at 4
o
C and the pellet resuspended in serum free RPM-1640. 
Translation of MV derived nucleic acid in CEM cells 
Shaved and non-shaved VLB100MVs (180 μg) were co-cultured with 1 x 10
5
 CEM cells 
to a final volume of 200 µL in complete RPMI medium supplemented with 10% FCS and 
maintained at 37
o
C, 5% CO2 in 96 well plates. At specific time intervals, cells were washed 
twice with pre-warmed (37
o
C) PBS to remove unbound MVs before Western blot analysis. 
CEM cells alone were used as the control. The newly translated P-gp was detected using the 
anti-P-gp antibody (clone F4, Sigma-Aldrich). 
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SDS-PAGE and Western Blotting 
The isolated MV pellet and cells were lysed in CelLytic M
TM
 Cell Lysis reagent (C2978; 
Sigma-Aldrich) in the presence of 1% (v/v) protease inhibitor cocktail (P8340, Sigma–Aldrich) 
on ice for 30 min. The lysates were centrifuged at 10,000 × g for 10 min at 4
o
C to pellet the 
debris. Total protein lysate was quantified using Qubit®2.0 Fluorometer (Invitrogen, Life 
Technologies) as per the manufacturer’s instructions. 
30-60 μg of total protein was separated by electrophoresis using a 4–12% NuPAGE 
Bis-Tris gel (Invitrogen, Life Technologies) at a constant voltage of 150 V for 60 min and 
transferred onto a PVDF membrane at 30 V for 90 min. For detection of P-gp and β-actin 
control, 1:1000 dilution of anti-P-gp mAb (Clone C219, Amersham Biosciences, Piscataway, 
NJ), 1:5000 dilution of anti-P-gp  (Clone F4, Sigma-aldrich, NSW, Australia) and 1:10,000 
dilution of anti-β-actin antibody (Clone AC-74, Sigma–Aldrich) was used. Incubation of 
antibodies was overnight at 4
o
C after blocking for 1 h with 5% skim milk in TBS and 0.05% 
Tween 20 (TBST). After washing 3 times in TBST, the membranes were incubated for 1 h 
with anti-Mouse-HRP secondary antibody (Promega, NSW, Australia) at 1:10,000 dilution. 
Novex® Sharp Pre-Stained standard (LC5800, Life technologies, Australia) was used as a 
molecular weight marker. Protein expression was visualised using an ECL (enhanced 
chemoluminescence) system (Roche Applied Science, NSW, Australia). The membranes were 
imaged using the luminescent image analyser LAS-3000 (Fujifilms, Brookvale, NSW, 
Australia). 
 
Calcein-AM dye exclusion assay 
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 Calcein-AM dye exclusion has been extensively used to measure P-gp and MRP1 
functionality (4, 11, 13). Briefly MVs isolated from VLB100 cells were co-cultured with 1× 10
5
 
CEM cells and maintained at 37
o
C and 5% CO2 in 96-well plates. After 4 hours, the recipient 
cells were washed twice with complete culture medium to remove unbound MVs and 
treated with 0.1 µM of Calcein-AM for 1 h in the presence and absence of a 1 h pre-
incubation with 10 μM cyclosporin A (CsA) (11) at 37
o
C and 5% CO2. The cells were 
subsequently washed three times with PBS and re-suspended in 200 μL PBS for flow 
cytometric analysis. 
Statistical Analysis 
Means between groups were compared using an unpaired two-tailed students t-test. 
P-values less than 0.05 (P < 0.05) were accepted as statistically significant. All statistical 
analyses were performed using GraphPad Prism version 5.0 for Windows Software 
(Graphpad Software, CA, USA). 
RESULTS 
 
MVs package functional ABCB1 transcript  
 We previously showed the packaging and transfer of mRNA encoding the ATP 
Binding Cassette superfamily of drug transporters (ABCB1 and ABCC1) by MVs into recipient 
cells (4, 6, 11). Herein, we sought to establish the functionality of these transferred 
transcripts in recipient cells following MV transfer. The functionality of MV packaged mRNA 
was first confirmed in vitro using a rabbit reticulocyte translation assay (RRTA). The 
expression of the cancer multidrug resistant protein, P-gp (coded by gene ABCB1) was used 
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as the reporter protein for the mRNA translation studies in the first instance. Using RRTA 
and the anti-P-gp clone F4 antibody, we observed a 170 kDa band (Figure 1) after the 
addition of total RNA purified from VLB100MVs (final 400 µg/mL) supporting in vitro 
translation of RNA into protein. We subsequently sought to examine the full repertoire of 
proteins translated using the RRTA system using shotgun proteomics (Table 1). We 
identified more than 200 proteins (Supplementary data Table 1) in our RRTA, of which 5 
were unique when compared to RRTA in absence of RNA (Table 1).  
 
MV-RNA is translated in recipient cells. 
To assess functionality of the transcripts in recipient cells following MV transfer of 
cargo, we first needed to eliminate detection of the endogenous transmembrane P-gp on 
the surface of MVs prior to co-culture with recipient cells.  Doing so would ensure that any 
protein detected in recipient cells was a function of translation of cargo transcript rather 
than the transfer of functional P-gp contained within the MV’s. In approaching this, we 
developed a novel approach using the non-specific protease, proteinase K, to cleave 
overhanging transmembrane segments of P-gp on the surface of MVs. Following which, we 
co-cultured the surface ‘shaved’ MVs with CEM cells to detect translation of full length 
protein from donor transcripts in the recipient cells.  
i. MV integrity is maintained following surface shaving 
MVs were isolated and validated as previously described by us (1, 3, 4, 6, 11). Using 
1.1 µM latex size beads (Sigma-Aldrich, NSW, Australia), events greater than 1.1 µM in size 
were excluded from flow cytometry (FCM) analysis by size gating (Figure 2A). VLB100MVs 
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were identified as Annexin-V450 positive events and represented 61.95% of the gated 
population (3, 4, 6). This result is consistent with our previous findings, which demonstrate 
spontaneous shedding of MVs from the P-gp overexpressing cell line, VLB100 (3, 4, 6).  
To confirm the membrane integrity of MV’s following surface shaving, we assessed 
the retention of intravesicular acridine orange (AO) and calcein-AM stains in MVs by FCM 
following dye loading as previously described by us  (Figure 2C, 2D). Calcein-AM is a 
membrane permeable non-fluorescent drug. Upon entering MVs, calcein-AM is cleaved by 
endogenous esterases to its fluorescent non-membrane permeable form, calcein, which 
remains trapped in the intravesicular space (4). We observed a small but significant 1.36 ± 
0.07 fold, (P < 0.05) increase in fluorescent calcein accumulation in MVs following surface 
shaving using 50 ng/mL Proteinase K. Despite this increase in calcein-AM permeability, we 
confirm the RNA content of shaved vesicles was not compromised as assessed by AO 
staining (Figure 3). We observed no significant difference in the AO fluorescence intensities 
when we compared shaved and non-shaved MVs, consistent with the maintenance of MV 
integrity and no leakage of the intra-vesicular nucleic acid material (Figure 3).  
ii. Surface peptide shaving does not compromise MV binding to 
recipient cells 
In assessing whether surface shaving impacted on cell binding of MV’s to recipient 
cells we co-cultured CEM cells with MVs preloaded and labelled with calcein-AM, AO and 
PKH26 (Figure 3). Whole cells were washed and analysed by FCM to determine the uptake 
of stained MVs following co-culture. Enhanced fluorescence was detected in recipient CEM 
cells following co-culture with shaved and non-shaved MVs relative to the unstained 
control. We observed no significant difference in MFI in recipient CEM cells after co-culture 
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with either shaved or non-shaved MVs. (Figure 3). This suggests that the binding of MVs 
shed from VLB100 cells does not require exposed surface proteins, with the process relying 
on the physical interaction between the two membranes (Figure 3). This is contrary to some 
previous reports that show that recognition between MVs and their target cells involves the 
specific interaction between proteins (eg. ICAM-1, CD44, LFA-1, H-2Kb and CD81) at the 
surface of both cells and MV (14-17). Here, the surface shaving of MVs with proteinase K, 
did not significantly affect binding of MV’s to recipient CEM cells. One possible reason for 
non-selectivity is the cell type in question, with the immunological origin of VLB100 MV’s and 
their reliance to interact with numerous cell types in the context of their immunological role 
 
iii. The molecular weight of P-gp changes following surface shaving 
Following proteinase K surface shaving we detected a change in the molecular 
weight of endogenous P-gp contained within the MV’s.  Specifically we observed a reduction 
of the proteins molecular weight from 170 kDa to the detection of multiple fragments 
around the 42 KDa size range (Figure 4). We observed a concentration dependent effect on 
the proteolytic digestion of P-gp. Treatment with 20 ng/mL of proteinase K for 5 min, 
resulted in a smearing around the 170 kDa region, consistent with incomplete shaving of 
surface peptides. Upon treatment with 50 ng/mL or more of proteinase K, we observed a 
complete loss of the 170 kDa band consistent with the proteolytic digestion of the protein 
(Figure 3).   
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iv. Newly synthesized full length P-gp is detectable in recipient cells 
following MV co-culture 
In detecting functionality of the transferred nucleic acid transcript in recipient cells, 
shaved VLB100MVs were co-cultured with recipient CEM cells, the latter inherently devoid of 
P-gp expression (Figure 5). Considering that human P-gp has a turnover of approximately 
18.3 h (18), we co-cultured for periods of 19 h and 24 h.  We observed a 170 kDa P-gp band 
in recipient CEM cells by Western blot analysis at both time points (Figure 5). The presence 
of the P-gp band is consistent with the transfer and translation of the ABCB1 transcript in 
recipient cells following MV co-culture.   
 
Newly synthesised P-gp is functional in the recipient cells. 
To investigate the drug efflux functionality of the newly translated P-gp in the 
recipient cells, the calcein-AM dye exclusion assay was used following a 4 h and 24 h co-
culture with shaven MV’s (Figure 6). The exclusion of calcein-AM in P-gp expressing cells is 
dependent on the functionality of the protein and is commonly used in the assessment of P-
gp mediated MDR (4, 11, 19).  We previously reported the transfer and functionality of P-gp 
in recipient CEM cells following a 4 h co-culture period and attributed this to the transfer of 
functional P-gp contained within the MV’s (3). Following 4 h co-culture with shaven 
VLB100MVs we observed no significant difference in calcein accumulation (Figure 6), 
consistent with the loss of functionality following surface shaving. Upon 24 h co-culture with 
shaven MVs, we observed a significant 1.311 (± 0.072) fold decrease in calcein accumulation 
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in recipient cells (Figure 6), consistent with the presence of translated and functional 
protein at this time (Figure 5).  
To further validate the functionality of the newly translated protein in recipient cells, 
the effects of the P-gp inhibitor Cyclosporin A (CsA) were examined. In the presence of 10 
µM CsA, we observed a significant 1.37 (± 0.114) fold reversal of calcein accumulation 
relative to control CEM cells alone (Figure 6), consistent with the pharmacological inhibition 
of P-gp mediated transport of calcein in the recipient cells. Similarly, we observed a 
significant 2.37 (± 0.68) fold reversal in CsA treated control VLB100 cells compared to VLB100 
cells alone, demonstrating the inhibition of P-gp mediated drug efflux in our controls. These 
results evidence the presence of functional P-gp following MV transfer of functional nucleic 
acid in recipient cells.  
 
DISCUSSION 
 Currently there is no methodology that allows for the detection of newly synthesized 
proteins in their native form as a result of homotypic nucleic acid transfer by MVs. Previous 
studies that utilize cross-species co-culture models (8) or reporter gene methodologies to 
demonstrate mRNA functionality (7) do not reflective of the native endogenous state. We 
report for the first time the translation of native, unlabelled human MV-RNA in human 
recipient cells following intercellular transfer by MV’s.  
We confirm the packaging of functional transcripts in microvesicles using a RRTA. 
The observation of a 170 kDa P-gp band on Western blot after addition of VLB100MV total 
RNA into a RRTA system establish that MV’s carry intact functional transcripts (Figure 1). It 
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should be noted however, that post-translational glycosylation events may vary between 
batches (20). We further identify additional proteins translated from VLB100MV RNA using 
tandem mass spectrometry (Table 1). The reason for the large overlap between sample and 
background, we believe is due to the cross species conservation of proteins (21). We 
identify 5 unique proteins from the VLB100MV translation lysate including P-gp, 60S 
ribosomal protein L26, Isoform 2 of 4F2 cell-surface antigen heavy chain, proteasome 
subunit beta type 6 and sodium/potassium-transporting ATPase subunit alpha-4. These 
proteins are reported to play a significant role in human cancer tumorigenesis and 
multidrug resistance (Table 1).  
Using surface shaving methodology we demonstrate for the first time functionality 
of MV nucleic acid cargo through the translation of exogenously acquired ABCB1 transcripts 
from VLB100 MVs in recipient CEM cells. We first confirm the integrity of intravesicular 
content in MVs using Calcein-AM and AO. After treatment of shaved MVs with calcein-AM, 
we detect an increase in fluorescent calcein accumulation 1.36 ± 0.07 fold, (P < 0.05) (Figure 
2). This increase may be attributed to the increased permeability as a result of surface 
shaving. However, our observation of an increase, rather than a decrease of calcein 
accumulation, is indicative that MV contents remains trapped in the intravesicular space as 
calcein fluorescnce is dependent on the presence of cleavage of calcein AM by intravesicular 
esterases (Figure 2)(4, 11). We further confirm the integrity of the nucleic acid content 
within MVs using AO staining and observe no significant changes in fluorescence intensity in 
response to proteinase K treatment once again consistent with maintenance of integrity of 
MV content following shaving (Figure 3).  
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In determining the optimal concentration of proteinase K for surface peptide 
shaving, we perform a Western blot analysis on MVs (Figure 4). We determined that a 
minimum of 50 ng/mL was required to completely remove detection of full length 170 kDa 
P-gp by Western blot by cleave of its extracellular domains. Interestingly, we also observed 
a decrease in the 42 kDa β-actin detection. This data certainly may support penetration of 
the proteinase K within the intravesicular space, however it is also consistent with our 
previous finding, where we detected two distinct vesicle orientation with respect to 
proteins present on shed MVs (11). The inside-out vesicle orientation may also explain the 
exposure of otherwise internalised β-actin to proteinase K shaving. In addition, despite the 
addition of serine protease inhibitors (included with protease inhibitor cocktail) and 
multiple cold washes, there may exist some residual proteinase K activity which may 
subsequently cause further degradation of β-actin. Once again, regardless of the possibility 
of proteinase K activity, we confirm the integrity of MVs and packaged RNA cargo by calcein-
AM and acridine orange staining (Figure 3).  
For complete surface protein digestion, other studies have performed proteinase K 
shaving experiments with longer time frames (30 min – 3 h) and significantly increased 
concentrations of enzyme (µg amounts) (22-24).  It may be possible that due to our low 
proteinase K concentrations (50 ng/uL) and incubation period (5 min), that other membrane 
protein may remain intact. To adapt this method for detection of other unique proteins, this 
amount of proteinase K treatment may require additional proteinase K treatment 
optimization.  
We have also previously reported that MVs isolated from VLB100MVs contain on 
average 2.2 ng of total RNA for every 1 x 10
5 
MVs (11). On this basis, we do not expect to 
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observe a large amount of translated protein relative to parental cells. Our results are 
consistent with this as we detect a modest 170 kDa P-gp band in cells after co-culture with 
shaven MVs with Western blot analysis (Figure 5, Lane 3 and 4). This is the first 
demonstration of nucleic acid functionality using a human homotypic cell system. Our 
findings also demonstrate for the first time that MV nucleic acids are functional.  In the 
context of cancer MDR, these nucleic acids translate into functional P-gp in recipient cancer 
cells and hence confer a functional drug efflux capacity (Figure 6). We also previously 
established that co-culture with CEM-MPs for more than 15 h did not induce expression of 
P-gp (4). Hence MP’s or MP proteins do not indirectly induce transcription / translation of P-
gp.  
 We also establish that drug efflux capacity is not evident at 4 hours MV co-culture as 
we observed following a simple cell to cell transfer of functional proteins (3). Rather, 
functionality as presented in the data here required a longer period consistent with the 
additional time required for mRNA translation. This data again confirms that endogenous P-
gp is no longer functional, nor detectable, after proteinase K shaving (Figure 4, 6). However, 
after 24 hour of MV co-culture we observe a decrease in calcein accumulation in recipient 
cells, indicative of the acquisition of a functional drug efflux capacity following nucleic acid 
translation. This accumulation deficit was reversible with the addition of Cyclosporin A, 
consistent with the inhibition of newly translated functional P-gp (Figure 6). Although our 
experiments have focused on P-gp/ABCB1 transmembrane protein expression, this 
methodology may be adapted for the study of various membrane spanning proteins and 
their transcripts. This method has potential to be expanded for provide further possibilities 
in this regard.  
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Conclusions  
These results expand on our previous findings where we observed a “re-templating” 
of the recipient cell transcriptional landscape (4). We demonstrate the capacity of MV’s to 
alter the recipient cell P-gp production and subsequently alter cellular phenotypes through 
the intercellular transfer of functional nucleic acids. 
Our method allows for the observation of translated membrane proteins in a 
physiologically relevant host cell and eliminates the use of interspecies models and reporter 
markers.  This provides a physiologically relevant analysis of membrane protein expression 
from MV cargo.  
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FIGURE LEGENDS 
Figure 1. MV’s package functional ABCB1 transcript. Total RNA purified from VLB100MVs 
were translated to protein using the rabbit reticulocyte in vitro translation kit (Promega, 
NSW, Australia). Detection of newly synthesized P-gp was by Western blot analysis using the 
anti-P-gp antibody (C219, Amersham Bioscience, NJ, USA). Novex® Sharp Pre-Stained 
standard (LC5800, Life technologies, Australia) was used as a molecular weight marker. A 
170 kDa was detected with addition of total VLB100MV RNA. Data is representative of 2 
independent experiments. 
 
Figure 2. MV integrity is maintained following proteinase K shaving. (a) MV’s isolated from 
VLB100 were analysed by FCM. Latex beads (BD Bioscience) of 0.3 and 1.1 µM were used to 
define the upper and lower limit of the forward and side scatter (data not shown). (b) 
Shaved and unshaved MVs were stained for phosphatidylserine exposure using Annexin 
V450; unstained background control.  (c) Intravesicular calcein accumulation in shaved and 
unshaved VLB100 MVs with increasing proteinase K concentration. (d) Acridine orange 
stained shaved, unshaved VLB100 MVs and unstained background control.  Data is 
representative of three independent experiments 
 
Figure 3. RNA content and MV binding retained following MV shaving. VLB100MVs are 
shaved using 50 ng/mL of proteinase K for 5 minutes at 37
o
C. Shaved MVs and non-shaved 
MVs were stained with (a) acridine orange and (b) PKH26 prior to co-culture with CEM cells 
(4 hours). Recipient cells are analysed by FCM to determine extent of RNA transfer and MV 
binding from shaven relative to non-shaved MVs. Unlabelled CEM cells. Data is 
representative of 3 independent experiments. 
 
Figure 4. Surface shaving of P-gp by proteinase K. (a) Graphical representation of MV 
surface shaving methodology. Exposed surface peptides on P-gp are cleaved following 
treatment with proteinase K, reducing the overall molecular weight of membrane bound 
MV proteins. (b) Western blot detection of P-gp after surface shaving with increasing 
amounts of proteinase K. P-gp was detected using the anti-P-gp antibody, clone F4, Sigma-
Aldrich, NSW, Australia). β-actin was detected on proteinase-K treatments below 100 ng/mL 
(clone AC-74, Sigma-Aldrich). Novex® Sharp Pre-Stained standard (LC5800, Life technologies, 
Australia) was used as a molecular weight marker. Data is representative of 2-3 independent 
experiments.  
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Figure 5. Translation of MV contained ABCB1 transcript in recipient cells. (a) Graphical 
representation of translation of transferred MV RNA in recipient cells. Surface shaved 
VLB100MVs were co-cultured with drug sensitive CEM cells to allow transfer of MV mRNA 
cargo. Transferred ABCB1 transcript translates to a 170 kDa surface protein in recipient cells. 
(b) Translated P-gp/ABCB1  were detected using Western blot analysis. P-gp was detected in 
CEM cells after 19 h of co-culture with shaved VLB100MVs using anti-P-gp  mAb (Clone F4, 
Sigma-Aldrich, NSW, Australia).  All MV’s were shaven with 50 ng/uL of proteinase K for 5 
mins at 37
o
C with gentle shaking. Novex® Sharp Pre-Stained standard (LC5800, Life 
technologies, Australia) was used as a molecular weight marker. Data is representative of a 
typical experiment (n=2-3).  
 
Figure 6. Newly translated P-gp is functional. Calcein accumulation in CEM cells after (a) 4 h 
or (b) 24 h co-culture with shaved VLB100MVs. Data represents the fold decrease in calcein 
accumulation relative to CEM cells. A decrease in calcein accumulation in CEM cells was 
observed after a 24 h co-culture with shaved VLB100MVs. The accumulation deficit was 
reversed following CsA exposure. No significant shift in fluorescence was detected in CEM 
cells co-cultured with VLB100MVs after 4 h. Data represents the mean ± S.E.M of at least 3 
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Figure 5. Translation of MV contained ABCB1 transcript into recipient cells. (a) Graphical representation of 
translation of transferred MV RNA in recipient cells. Surface shaved VLB100MVs were co-cultured with drug 
sensitive CEM cells to allow transfer of MV mRNA cargo. Transferred ABCB1 transcript translates to a 170 
kDa surface protein in recipient cells. (b) Translated P-gp/ABCB1  were detected using Western blot 
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Figure 6. Newly translated P-gp is functional. Calcein accumulation in CEM cells after (a) 4 h or (b) 24 h co-
culture with shaved VLB100MVs. Data represents the fold decrease in calcein accumulation relative to CEM 
cells. A decrease in calcein accumulation in CEM cells was observed after a 24 h co-culture with shaved 
VLB100MVs. The accumulation deficit was reversed following CsA exposure. No significant shift in 
fluorescence was detected in CEM cells co-cultured with VLB100MVs after 4 h. Data represents the mean ± 
S.E.M of at least 3 independent experiments. *P < 0.05  
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Table 1. List of homo sapien proteins translated from VLB100MV RNA using rabbit lysate translation 
assay as analysed by LC/MS/MS 
No. Name of 
protein 
No of unique  
peptides detected  
in 3 independent 
replicates 
Function 
  Translation Background  
1 P-glycoprotein 
(P-gp) 
8-5-5 0-0-0 ATP-binding cassette transporter protein. 
Overexpression in cancer cells is strongly 
associated with MDR (3, 25).   
2 60S ribosomal 
protein L26 
(RPL26) 
2-2-0 0-0-0 Binding of RPL26 to the 5’UTR of p53 gene, 
modulate p53 protein levels and affect p53 
induction after DNA damage. P53 gene is 
commonly mutated in human cancer and lead to 
the cancer-predisposing Li-Fraumeni syndrome 
(26).  
Ribosomal proteins are reported to be increased 
in human cancer and in maintaining cancer 
phenotype (27, 28). 





3-1-3 0-0-0 SLC3A2 is the protein that is encoded by SLC3A2 
gene, which binds to a highly conserved C-
terminal domain of integrin β1A and β3 
cytoplasmic subunits, thereby affecting the 
integrin signalling cascade (29). 
These proteins influences malignant tumour cell 
behaviour and overexpressed in variety of 





2-2-1 0-0-0 PSMB6 is a member of 20S proteasomal subunit 
family, which forms the proteolytic core of 26S 
proteasome. Enhanced proteasomal activity has 
been demonstrated as a mediator of resistance 
to chemotherapy (31).  
Over expression of the PSMB1 proteasomal 







subunit is associated with resistance to cisplatin 
in cancer cell lines (32) and associated with 







2-0-2 0-0-0 ATP1A4 was reported to overexpressed in 
pancreas tumour compared with normal cells 
(34). 
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